NCT06202248View on ClinicalTrials.gov

A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Non-metastatic Prostate CancerLocally Recurrent Prostate Cancer
Interventions
DEVICE

Experimental: DaRT seeds

Intratumoral Diffusing alpha-emitters Radiation Therapy (DaRT) Seeds

Trial Locations (1)

3109601

RECRUITING

RAMBAM Health Care Campus, Haifa

Sponsors
All Listed Sponsors
lead

Alpha Tau Medical LTD.

INDUSTRY